pLX302 Luciferase-V5 puro Citations (3)

Originally described in: Simultaneous profiling of 194 distinct receptor transcripts in human cells.
Kang BH, Jensen KJ, Hatch JA, Janes KA Sci Signal. 2013 Aug 6;6(287):rs13. doi: 10.1126/scisignal.2003624. PubMed Journal

---

Articles Citing pLX302 Luciferase-V5 puro

Articles
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Wang M, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Ferreira RB, Chiang CW, Guryanova OA, Kopinke D, Heldermon CD, Castellano RK, Law BK. Cell Death Discov. 2019 Dec 10;5:153. doi: 10.1038/s41420-019-0228-9. eCollection 2019. PubMed
EVI/WLS function is regulated by ubiquitylation and is linked to ER-associated degradation by ERLIN2. Wolf LM, Lambert AM, Haenlin J, Boutros M. J Cell Sci. 2021 Aug 15;134(16). pii: 271857. doi: 10.1242/jcs.257790. Epub 2021 Aug 18. PubMed
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC. Bopple K, Oren Y, Henry WS, Dong M, Weller S, Thiel J, Kleih M, Gaissler A, Zipperer D, Kopp HG, Aylon Y, Oren M, Essmann F, Liang C, Aulitzky WE. Cell Death Dis. 2024 Apr 24;15(4):290. doi: 10.1038/s41419-024-06674-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.